SAMN46298545
External Id
dbGaP
INSDC center name
2025-01-18T04:29:18.717Z
INSDC first public
2025-04-12T04:52:22.607Z
INSDC last update
SRS23826516
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS23826516
SRA accession
RNA
analyte type
NCI_AnakinraProphylaxis
biospecimen repository
Pool_CARneg_1_2_3_4_5
biospecimen repository sample id
Peripheral blood
body site
phs003655
gap_accession
1
gap_consent_code
HMB
gap_consent_short_name
7268898
gap_sample_id
5343666
gap_subject_id
No
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
Case Set
study design
Anakinra
study disease
Efficacy and Immune Effects of Anakinra Prophylaxis for Neurologic Toxicity and Cytokine Release Syndrome in Patients with Lymphoma Receiving Axicabtagene Ciloleucel
study name
Yes
subject is affected
Pool_CARneg_1_2_3_4_5
submitted sample id
Pool_1_2_3_4_5
submitted subject id
NCI_AnakinraProphylaxis
submitter handle
Non-tumor RNA sample from Peripheral blood of a human participant in the dbGaP study "Efficacy and Immune Effects of Anakinra Prophylaxis for Neurologic Toxicity and Cytokine Release Syndrome in Patients with Lymphoma Receiving Axicabtagene Ciloleucel"
title